Publications

5674 Results

Discovery of molecular predictors of late breast cancer specific events (BCSE) in ER+, node+ breast cancer - new transcriptome expression whole gene analysis of the phase III adjuvant trial SWOG S8814

Authors
K Albain;M Crager;W Barlow;F Baehner;A Bergamaschi;JM Rae;P Ravdin;D Tripathy;J Gralow;RB Livingston;CK Osborne;JN Ingle;K Pritchard;NE Davidson;LA Carey;DB Cherbavaz;AP Sing;G Hortobagyi;DF Hayes
Journal / Conference
San Antonio Breast Cancer Symposium (Dec 6-10, 2016, San Antonio, TX), poster discussion, #PD7-07
Year
2016
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

E1505: Adjuvant chemotherapy +/- bevacizumab for early stage NSCLC—Outcomes based on chemotherapy subsets

Authors
H Wakelee;S Dahlberg;S Keller;W Tester;D Gandara;S Graziano;A Adjei;N Leighl;C Butts;S Aisner;J Rothman;J Patel;M Sborov;R McDermott;R Perez-Soler;A Traynor;T Evans;L Horn;S Ramalingam;J Schiller
Journal / Conference
Journal of Clinical Oncology 34, 2016 (suppl; abstr 8507); American Society of Clinical Oncology Annual Meeting (June 3-7, 2016, Chicago, IL), oral session
Year
2016
Research Committee(s)
Lung
Study Number(s)
CTSU/E1505

Enrollment trends and disparity among patients with lung cancer in national clinical trials, 1990 to 2012

Authors
HH Pang;X Wang;T Stinchcombe;M Wong;P Cheng;AK Ganti;D Sargent;Y Zhang;C Hu;S Mandrekar;M Redman;J Manola;R Schilsky;H Cohen;J Bradley;A Adjei;D Gandara;S Ramalingam;E Vokes
Journal / Conference
Journal of Clinical Oncology Nov 20 34(33):3992-3999; 2016 Sep 19 [Epub ahead of print]
Year
2016
Research Committee(s)
Lung
PMID
PMID27646951
PMC
PMC5477832

MGUS to myeloma: a mysterious gammopathy of underexplored significance

Authors
M Dhodapkar
Journal / Conference
Blood 128:2599-2606 [Perspectives]
Year
2016
Research Committee(s)
Myeloma
PMID
PMID27737890
PMC
PMC5146746
Study Number(s)
S0120

Breast cancer outlook for 2017: keeping the accelerator to the floor

Authors
V Gadi;J Gralow
Journal / Conference
Oncology (Williston Park)
Year
2016
Research Committee(s)
Breast
PMID
PMID27933601
Study Number(s)
S1416

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II–III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)

Authors
M Golshan;C Cirrincione;W Sikov;LA Carey;DA Berry;BA Overmoyer;NL Henry;G Somlo;E Port;H Burstein;C Hudis;E Winer;D Ollila
Journal / Conference
Breast Cancer Research and Treatment
Year
2016
Research Committee(s)
Breast
PMID
PMID27704226
PMC
PMC5189982

Relationship between metformin use and recurrence and survival in patients with resected stage III colon cancer receiving adjuvant chemotherapy: results from North Central Cancer Treatment Group N0147 (Alliance)

Authors
P Singh;Q Shi;N Foster;A Grothey;S Nair;E Chane;A Shields;R Goldberg;S Gill;M Kahlenberg;F Sinicrope;D Sargent;S Alberts
Journal / Conference
Oncologist Dec;21(12):1509-1521; Epub 2016 Nov 23
Year
2016
Research Committee(s)
Gastrointestinal
PMID
PMID27881709
PMC
PMC5153338
Study Number(s)
CTSU/N0147

Adverse health effects of intermittent vs continuous androgen deprivation therapy for metastatic prostate cancer - Reply

Authors
D Hershman;J Unger
Journal / Conference
JAMA Oncology May 1;2(5):686-687
Year
2016
Research Committee(s)
Genitourinary
PMID
PMID27244679
Study Number(s)
SWOG-9346

Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia

Authors
Gu Z;M Churchman;K Roberts;Y Li;R Harvey;K McCastlain;S Reshmi;D Payne-Turner;I Iacobucci;Y Shao;IM Chen;M Valentine;D Pei;K Mungall;A Mungall;Y Ma;R Moore;M Marra;E Stonerock;J Gastier-Foster;M Devidas;Y Dai;B Wood;M Borowitz;E Larsen;K Maloney;L Mattano;A Angiolillo;W Salzer;M Burke;F Gianni;O Spinnelli;JP Radich;MD Minden;A Moorman;B Patel;A Fielding;J Rowe;S Luger;R Bhatia;I Aldoss;SJ Forman;J Kohlschmidt;K Mrozek;G Marcucci;C Bloomfield;W Stock;W Kornblau;H Kantarjian;M Konopleva;E Paietta;C Willman;M Loh;S Hunger;C Mullighan
Journal / Conference
Nature Communications Nov 8;7:13331
Year
2016
Research Committee(s)
Leukemia
PMID
PMID27824051
PMC
PMC5105166
Study Number(s)
S0333, SWOG-9400, S9910

S0502: A SWOG phase III randomized study of imatinib, with or without bevacizumab, in patients with untreated metastatic or unresectable gastrointestinal stromal tumors

Authors
CD Blanke;C Rankin;C Corless;J Eary;P Okuno;S George;M Heinrich
Journal / Conference
The Oncologist Dec;20(12):1353-1354
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID26576593
PMC
PMC4679092
Study Number(s)
S0502